Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. South Africa
  4. Johannesburg Stock Exchange
  5. Aspen Pharmacare Holdings Limited
  6. Financials
    APN   ZAE000066692

ASPEN PHARMACARE HOLDINGS LIMITED

(APN)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: June 2019 2020 2021 2022 2023 2024
Capitalization1 45 80265 41273 83698 361--
Enterprise Value (EV)1 84 786100 64090 136112 246107 261100 860
P/E ratio 6,38x14,0x15,4x15,0x11,1x10,8x
Yield 3,14%-1,62%1,36%1,66%1,66%
Capitalization / Revenue 1,18x1,69x1,96x2,40x2,05x1,88x
EV / Revenue 2,18x2,60x2,39x2,74x2,24x1,93x
EV / EBITDA 7,83x9,18x9,06x10,5x8,20x7,37x
Price to Book 0,83x0,95x1,13x1,35x1,24x1,15x
Nbr of stocks (in thousands) 455 970455 800455 522455 165--
Reference price (ZAR) 100144162216216216
Announcement Date 09/11/201909/09/202009/01/2021---
1 ZAR in Million
Previous periodNext period
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: June 2019 2020 2021 2022 2023 2024
Net sales1 38 87238 64737 76640 96847 95252 268
EBITDA1 10 82410 9689 94510 66613 08413 678
Operating profit (EBIT)1 5 5287 0607 0728 92111 34211 898
Operating Margin 14,2%18,3%18,7%21,8%23,7%22,8%
Pre-Tax Profit (EBT)1 3 4905 6025 9897 80811 17711 475
Net income1 7 1824 6644 8066 4397 4687 459
Net margin 18,5%12,1%12,7%15,7%15,6%14,3%
EPS2 15,710,210,514,419,519,9
Dividend per Share2 3,15-2,622,933,593,58
Announcement Date 09/11/201909/09/202009/01/2021---
1 ZAR in Million
2 ZAR
Previous periodNext period
Income Statement Evolution (Quarterly data)
Fiscal Period: June 2018 S2 2019 S2 2020 S1
Net sales1 20 67219 19918 417
EBITDA1 5 7255 2905 260
Operating profit (EBIT)1 4 0724 7043 644
Operating Margin 19,7%24,5%19,8%
Pre-Tax Profit (EBT)1 2 904-2 969
Net income1 2 331-2 629
Net margin 11,3%-14,3%
EPS ---
Dividend per Share ---
Announcement Date 09/13/201809/11/201903/05/2020
1 ZAR in Million
Balance Sheet Analysis
Fiscal Period: June 2019 2020 2021 2022 2023 2024
Net Debt1 38 98435 22816 30013 8848 9002 499
Net Cash position1 ------
Leverage (Debt / EBITDA) 3,60x3,21x1,64x1,30x0,68x0,18x
Free Cash Flow1 3 5605 5703 39416 84310 02310 482
ROE (Net Profit / Equities) 12,4%10,8%8,87%9,36%11,0%11,0%
Shareholders' equity1 58 01843 05654 20368 83067 60367 900
ROA (Net Profit / Asset) 5,06%5,23%4,92%6,60%11,0%9,30%
Assets1 141 95689 12497 62197 56667 89280 200
Book Value Per Share2 120152144160175187
Cash Flow per Share2 13,118,115,017,718,919,0
Capex1 3 5832 6903 4313 0001 7501 786
Capex / Sales 9,22%6,96%9,08%7,32%3,65%3,42%
Announcement Date 09/11/201909/09/202009/01/2021---
1 ZAR in Million
2 ZAR
Previous periodNext period
Key data
Capitalization (ZAR) 98 361 127 542
Capitalization (USD) 6 525 780 221
Net sales (ZAR) 37 766 000 000
Net sales (USD) 2 500 713 456
Number of employees 8 844
Sales / Employee (ZAR) 4 270 240
Sales / Employee (USD) 282 758
Avg. Exchange 20 sessions (ZAR) 205 841 301
Avg. Exchange 20 sessions (USD) 13 629 988
Average Daily Capital Traded 0,21%
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA